Benefits of bifidobacterium animalis subsp. lactis probiotic in experimental periodontitis

Journal of Periodontology

Volumn 88, Issue 2, 2017, Pages 197-208

  Oliveira, Luiz F F ^a   Salvador, Sérgio L ^a   Silva, Pedro H F ^a   Furlaneto, Flávia A C ^a   Figueiredo, Luciene ^a   Casarin, Renato ^b   Ervolino, Edilson ^c   Palioto, Daniela B ^a   Souza, Sérgio L S ^a   Taba, Mario ^a   Novaes, Arthur B ^a   Messora, Michel R ^d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b GUARULHOS UNIVERSITY   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Alveolar bone loss; Bifidobacterium; Periodontal attachment loss; Periodontitis; Probiotics; Rats

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; PROBIOTIC AGENT;

ANIMAL; BIFIDOBACTERIUM ANIMALIS; BIOFILM; DISEASE MODEL; ENZYME IMMUNOASSAY; MALE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; MICROBIOLOGY; PERIODONTITIS; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RAT; TOPICAL DRUG ADMINISTRATION; WISTAR RAT;

ADMINISTRATION, TOPICAL; ANIMALS; BIFIDOBACTERIUM ANIMALIS; BIOFILMS; BIOMARKERS; CYTOKINES; DISEASE MODELS, ANIMAL; IMMUNOENZYME TECHNIQUES; MALE; PERIODONTITIS; POLYMERASE CHAIN REACTION; PROBIOTICS; RATS; RATS, WISTAR; X-RAY MICROTOMOGRAPHY;

EID: 85012023550     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2016.160217     Document Type: Article

References (49)

1. Food and Agriculture Organization of the United Nations; World Health Organization. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, report of a Joint FAO/WHO Expert Consultation, Cordoba, Argentina, 1-4 October 2001. Available at: ftp://ftp.fao.org/es/esn/food/probio-report-en.pdf. Accessed June 28, 2016.
2. Whitford EJ, Cummins AG, Butler RN, et al. Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent 5-Fluorouracil (5-FU). Cancer Biol Ther 2009;8:505-511.
3. Teughels W, Loozen G, Quirynen M. Do probiotics offer opportunities to manipulate the periodontal oral microbiota? J Clin Periodontol 2011;38(Suppl. 11):159-177.
4. Haukioja A, Loimaranta V, Tenovuo J. Probiotic bacteria affect the composition of salivary pellicle and streptococcal adhesion in vitro. Oral Microbiol Immunol 2008;23:336-343.
5. İnce G, Gürsoy H, İpçi ŞD, Cakar G, Emekli-Alturfan E, Yilmaz S. Clinical and biochemical evaluation of lozenges containing Lactobacillus reuteri as an adjunct to non-surgical periodontal therapy in chronic periodontitis. J Periodontol 2015;86:746-754.
6. Tekce M, Ince G, Gursoy H, et al. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: A 1-year follow-up study. J Clin Periodontol 2015;42:363-372.
7. Morales A, Carvajal P, Silva N, et al. Clinical effects of Lactobacillus rhamnosus in non-surgical treatment of chronic periodontitis: A randomized placebo-controlled trial with 1-year follow-up. J Periodontol 2016;87: 944-952.
8. Hojo K, Mizoguchi C, Taketomo N, et al. Distribution of salivary Lactobacillus and Bifidobacterium species in periodontal health and disease. Biosci Biotechnol Biochem 2007;71:152-157.
9. Russell DA, Ross RP, Fitzgerald GF, Stanton C. Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol 2011;149:88-105.
10. Caglar E, Kuscu OO, Selvi Kuvvetli S, Kavaloglu Cildir S, Sandalli N, Twetman S. Short-term effect of icecream containing Bifidobacterium lactis Bb-12 on the number of salivary mutans streptococci and lactobacilli. Acta Odontol Scand 2008;66:154-158.
11. Toiviainen A, Jalasvuori H, Lahti E, et al. Impact of orally administered lozenges with Lactobacillus rhamnosus GG and Bifidobacteriumanimalis subsp. lactis BB-12 on the number of salivary mutans streptococci, amount of plaque, gingival inflammation and the oral microbiome in healthy adults. Clin Oral Investig 2015;19:77-83.
12. Sanders ME. Summary of probiotic activities of Bifidobacterium lactis HN019. J Clin Gastroenterol 2006;40: 776-783.
13. Shu Q, Lin H, Rutherfurd KJ, et al. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiol Immunol 2000;44:213-222.
14. Shu Q, Qu F, Gill HS. Probiotic treatment using Bifidobacterium lactis HN019 reducesweanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J Pediatr Gastroenterol Nutr 2001;33: 171-177.
15. Messora MR, Pereira LJ, Foureaux R, et al. Favourable effects of Bacillus subtilis and Bacillus licheniformis on experimental periodontitis in rats. Arch Oral Biol 2016; 66:108-119.
16. Chitprasert P, Sudsai P, Rodklongtan A. Aluminum carboxymethyl cellulose-rice bran microcapsules: Enhancing survival of Lactobacillus reuteri KUB-AC5. Carbohydr Polym 2012;90:78-86.
17. Messora MR, Oliveira LFF, Foureaux RC, et al. Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligatureinduced periodontitis. JPeriodontol 2013;84:1818-1826.
18. Socransky SS, Smith C, Martin L, Paster BJ, Dewhirst FE, Levin AE. "Checkerboard" DNA-DNA hybridization. Biotechniques 1994;17:788-792.
19. Duarte PM, Tezolin KR, Figueiredo LC, Feres M, Bastos MF. Microbial profile of ligature-induced periodontitis in rats. Arch Oral Biol 2010;55:142-147.
20. Junick J, Blaut M. Quantification of human fecal bifidobacterium species by use of quantitative realtime PCR analysis targeting the groEL gene. Appl Environ Microbiol 2012;78:2613-2622.
21. Furlaneto FA, Nunes NL, Oliveira Filho IL, et al. Effects of locally administered tiludronic acid on experimental periodontitis in rats. J Periodontol 2014;85:1291-1301.
22. Weichert S, Schroten H, Adam R. The role of prebiotics and probiotics in prevention and treatment of childhood infectious diseases. Pediatr Infect Dis J 2012;31: 859-862.
23. Abusleme L, Dupuy AK, Dutzan N, et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J 2013;7:1016-1025.
24. Cosseau C, Devine DA, Dullaghan E, et al. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun 2008;76:4163-4175.
25. Kumar PS, Mason MR. Mouthguards: Does the indigenous microbiome play a role in maintaining oral health? Front Cell Infect Microbiol 2015;5:35.
26. Isogai E, Isogai H, Sawada H, Kaneko H, Ito N. Microbial ecology of plaque in rats with naturally occurring gingivitis. Infect Immun 1985;48:520-527.
27. Twetman L, Larsen U, Fiehn NE, Stecksén-Blicks C, Twetman S. Coaggregation between probiotic bacteria and caries-associated strains: An in vitro study. Acta Odontol Scand 2009;67:284-288.
28. Haukioja A, Yli-Knuuttila H, Loimaranta V, et al. Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. Oral Microbiol Immunol 2006;21:326-332.
29. Gordon DM. The potential of bacteriocin-producing probiotics and associated caveats. Future Microbiol 2009;4:941-943.
30. Oelschlaeger TA. Mechanisms of probiotic actions - A review. Int J Med Microbiol 2010;300:57-62.
31. Jäsberg H, Söderling E, Endo A, Beighton D, Haukioja A. Bifidobacteria inhibit the growth of Porphyromonas gingivalis but not of Streptococcus mutans in an in vitro biofilm model. Eur J Oral Sci 2016;124:251-258.
32. Mottet C, Michetti P. Probiotics: Wanted dead or alive. Dig Liver Dis 2005;37:3-6.
33. Szkaradkiewicz AK, Stopa J, Karpiński TM. Effect of oral administration involving a probiotic strain of Lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis. Arch Immunol Ther Exp (Warsz) 2014;62:495-500.
34. Martins AK, Martins FS, Gomes DA, et al. Evaluation of in vitro antagonism and of in vivo immune modulation and protection against pathogenic experimental challenge of two probiotic strains of Bifidobacterium animalis var. lactis. Arch Microbiol 2010;192:995-1003.
35. Čitar M, Hacin B, Tompa G, et al. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells. Benef Microbes 2015;6:325-336.
36. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
37. Teles RP, Gursky LC, Faveri M, et al. Relationships between subgingival microbiota and GCF biomarkers in generalized aggressive periodontitis. J Clin Periodontol 2010;37:313-323.
38. Kajiya M, Giro G, Taubman MA, Han X, Mayer MP, Kawai T. Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease. J Oral Microbiol 2010;2:5532.
39. Britton RA, Irwin R, Quach D, et al. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomizedmousemodel. J Cell Physiol 2014;229:1822-1830.
40. Ohlsson C, Engdahl C, Fåk F, et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS One 2014;9:e92368.
41. Parvaneh K, Ebrahimi M, Sabran MR, et al. Probiotics (Bifidobacterium longum) increase bone mass density and upregulate Sparc and Bmp-2 genes in rats with bone loss resulting from ovariectomy. Biomed Res Int 2015;2015:897639.
42. Wang WM, Ye P, Qian YJ, et al. Effects of whole cigarette smoke on human beta defensins expression and secretion by oral mucosal epithelial cells. Tob Induc Dis 2015;13:3.
43. Kuula H, Salo T, Pirilä E, et al. Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis. Arch Oral Biol 2008;53:175-186.
44. Brancatisano FL, Maisetta G, Barsotti F, et al. Reduced human beta defensin 3 in individuals with periodontal disease. J Dent Res 2011;90:241-245.
45. Liu J, Chen J, Du X, Hu L, Chen L. The expression of hBDs in the gingival tissue and keratinocytes from healthy subjects and periodontitis patients. Arch Oral Biol 2014;59:193-198.
46. Dommisch H, Reinartz M, Backhaus T, Deschner J, Chung W, Jepsen S. Antimicrobial responses of primary gingival cells to Porphyromonas gingivalis. J Clin Periodontol 2012;39:913-922.
47. Varoga D, Tohidnezhad M, Paulsen F, et al. The role of human β-defensin-2 in bone. J Anat 2008;213:749-757.
48. Varoga D, Wruck CJ, Tohidnezhad M, et al. Osteoblasts participate in the innate immunity of the bone by producing human β defensin-3. Histochem Cell Biol 2009;131:207-218.
49. Kraus D, Deschner J, Jäger A, et al. Human β-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J Cell Physiol 2012;227:994-1003.